$REGN Recent News Nasdaq falls for 4th day in row; Dow,

New Post Public Reply Private Reply Replies (0) Message Board

Mar 14, 2014 at 12:52 PM

$REGN Recent News

Nasdaq falls for 4th day in row; Dow, S&P slip for 2nd day: stock market live blog recap 3:51 p.m. March 11, 2014 - blogs.marketwatch.com
Bull market’s biggest winners and losers 7:00 a.m. March 10, 2014 - Jeff Reeves
Lorillard and Reynolds jump on buyout report 5:16 p.m. March 3, 2014 - Sue Chang
Sprint gains on narrower loss; WPX tops S&P 500 losers 5:15 p.m. Feb. 11, 2014 - Sue Chang
Dow nabs best gain of year after Yellen remarks, debt-ceiling news: stock market live blog recap 4:55 p.m. Feb. 11, 2014 - blogs.marketwatch.com
Regeneron diabetic eye remedy does well in trial 9:02 a.m. Feb. 10, 2014 - MarketWatch.com
Stocks stabilize; now it’s up to Yellen, the consumer 9:01 a.m. Feb. 9, 2014 - Wallace Witkowski
Tesla extends gains; ExOne sinks on revenue warning 4:45 p.m. Jan. 15, 2014 - Sue Chang
GameStop tumbles 20%; Tesla surges on strong sales 5:23 p.m. Jan. 14, 2014 - Sue Chang
Regeneron climbs by double-digits, leads S&P after presentation 4:58 p.m. Jan. 14, 2014 - Russ Britt
Dow jumps 116 points, best day this year: Stock market live blog recap 4:51 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Three biopharma companies poised for product OKs in 2014: analyst 1:51 p.m. Jan. 6, 2014 - Russ Britt
Goldman's biotech downgrade and the new consensus 12:53 p.m. Jan. 6, 2014 - MarketWatch.com
Apple off on market data, Twitter down as options debut 5:36 p.m. Nov. 15, 2013 - Sue Chang
Macy's, Potbelly gain; Chegg slumps in debut 6:04 p.m. Nov. 13, 2013 - Sue Chang
GT spikes on sapphire deal with Apple 5:45 p.m. Nov. 5, 2013 - Sue Chang
Regeneron shares near $300 as earnings report emboldens investors 12:14 p.m. Nov. 5, 2013 - Russ Britt
The next big pharma 7:01 a.m. Oct. 25, 2013 - The Trading Deck
Apple extends gains on price target hike 3:47 p.m. Oct. 16, 2013 - Sue Chang
Apple gains on upgrade; BlackBerry rallies 4:34 p.m. Oct. 7, 2013 - Sue Chang

Piper Jaffray Stocks to Buy for S&P 500 Going to 2,100 8:00 a.m. March 13, 2014 - 247WallSt.com
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
Next Stop for the Nasdaq: 5000 3:33 a.m. March 8, 2014 - Barrons.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:17 p.m. March 7, 2014 - TheStreet.com
FDA Advises of Adverse Effects from New Cholesterol Drugs 6:08 p.m. March 7, 2014 - The Wall Street Journal Interactive Edition
Regeneron and Sanofi to look into side effects of cholesterol drug candidate 4:24 p.m. March 7, 2014 - Seeking Alpha
3 Stocks Reiterated As A Hold: FCX, TSLA, REGN 3:01 p.m. March 7, 2014 - TheStreet.com
Water-Logged And Getting Wetter: Regeneron Pharmaceuticals (REGN) 1:17 p.m. March 7, 2014 - TheStreet.com
Regeneron Cholesterol-Drug Worries Ding Stock 1:11 p.m. March 7, 2014 - Investors Business Daily
Insider Trading Alert - CNW, PPS And REGN Traded By Insiders 11:45 a.m. March 6, 2014 - TheStreet.com
10 Best Stocks Since the Bull Market Began 10:15 a.m. March 6, 2014 - InvestorPlace.com
Update on Bayer/Regeneron's Eylea - Analyst Blog 4:55 p.m. March 5, 2014 - Zacks.com
Regeneron Pharmaceuticals (REGN) Hits New Lifetime High Today 9:45 a.m. March 5, 2014 - TheStreet.com
Cramer's Mad Money - 5 Putin-Proof Sectors (3/4/14) 6:13 a.m. March 5, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Stocks on Sale 8:08 p.m. March 4, 2014 - TheStreet.com
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Winner 5:00 p.m. March 3, 2014 - TheStreet.com
Regeneron announces regulatory submission in Japan 10:20 a.m. March 3, 2014 - Seeking Alpha
Bayer: Xarelto and Eylea to reach peak revenues in 5-6 years 7:37 a.m. Feb. 28, 2014 - Seeking Alpha
Regeneron Pipeline Could Be The Big Story In 2014 5:30 p.m. Feb. 27, 2014 - Investors Business Daily
Biotech Stock Roundup: Isis Soars on Positive Data, Onconova Falls - Analyst Blog 10:26 a.m. Feb. 26, 2014 - Zacks.com

Marketing Authorization Applications, Quarterly Dividends, Publication of Clinical Trial Data, Acquisitions, and Financial Results - Analyst Notes on Regeneron, Amgen, Sangamo, Alnylam, and Agios 9:08 a.m. March 11, 2014 - PR Newswire - PRF
Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare 11:50 a.m. March 6, 2014 - PR Newswire - PRF
Bayer HealthCare and Regeneron Announce Regulatory Submission of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Japan 2:00 a.m. March 3, 2014 - PR Newswire - PRF
Critical Alerts For Walter Energy, Regeneron, Biogen Idec, Red Hat, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. Feb. 27, 2014 - PR Newswire - PRF
Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for the Treatment of Macular Edema Following Branch Retinal Vein Occlusion 7:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
Regeneron Announces Upcoming 2014 Investor Conference Presentations 9:30 a.m. Feb. 14, 2014 - PR Newswire - PRF
Regeneron Reports Fourth Quarter and Full Year 2013 Financial and Operating Results 6:30 a.m. Feb. 11, 2014 - PR Newswire - PRF
Two-Year Results From Phase 3 VISTA Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision 7:30 a.m. Feb. 10, 2014 - PR Newswire - PRF
Critical Alerts For Intel, Regeneron, Lowes, eBay, and KB Homes Released By InvestorsObserver 9:31 a.m. Jan. 23, 2014 - PR Newswire - PRF
Regeneron to Report Fourth Quarter and Full Year 2013 Financial and Operating Results and Host Conference Call and Webcast on February 11, 2014 9:30 a.m. Jan. 21, 2014 - PR Newswire - PRF
Regeneron and Bayer to Develop New Treatment Option for Wet Age-Related Macular Degeneration 4:05 p.m. Jan. 13, 2014 - PR Newswire - PRF
Regeneron and Geisinger Health System Announce Major Human Genetics Research Collaboration 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Regeneron Launches New Human Genetics Initiative 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Regeneron Announces Amendment to Investor Agreement with Sanofi 2:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 8:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 8:00 a.m. Dec. 31, 2013 - PR Newswire
Critical Alerts For Stratasys, Regeneron, Ctrip, Paychex, and Tyson Released By InvestorsObserver 9:31 a.m. Dec. 23, 2013 - PR Newswire
Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals 8:00 a.m. Dec. 19, 2013 - PR Newswire
Sanofi and Regeneron Announce Collaboration with American College of Cardiology for PCSK9 Inhibitor Clinical Program 1:00 a.m. Dec. 19, 2013 - PR Newswire
Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication 7:30 a.m. Dec. 18, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quest Diagnostics at Jefferies Conference: What’s Next?

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Greenberg Traurig Expands Franchise Team with Tuneski

DC’s Legal Landscape Shifts with Tuneski’s Move Greenberg Traurig's Washington, D.C., office just dialed it up a notch by bringing in Alexander Tuneski. A guy like this crossing the floor from DLA Piper is big news. This isn’t just any legal bean counter; with over 20 years under his belt, Tuneski knows franchise law like the back of his hand. And when you've been...

Envision and ju:niz Boost Germany's Energy Storage

Germany Charges Ahead with Renewable Energy Storage Germany's on a mission, folks, and it's all about beefing up their renewable energy infrastructure. Out in Bavaria, Envision Energy and ju:niz Energy are prepping a significant leap forward. They're rolling out a big undertaking—a 442 MWh battery energy storage system (BESS) with their Smareg 13 project in Vöhringen....

Paul Taubman Takes Helm at Cold Spring Harbor Lab

Paul Taubman Steers the Ship at CSHL Here's the buzz coming out of Cold Spring Harbor Lab: they're handing the reins over to Paul Taubman. It's like swapping captains in the middle of the ocean—big shoes need to stay afloat. This place isn't just the playground for science nerds; it's a powerhouse in biomedical research. Now, we've got Taubman, a fella who's been...

Deadline Looms for BETR Investors: Take Action Now

What’s the Fuss About? Alright folks, let’s lay this out simple: Better Home & Finance Holding Company (NASDAQ: BETR) is in hot water. A class action’s been slapped on them, accusing the firm of sugarcoating its business prospects. If you bought BETR shares between March 13, 2026, and May 7, 2026, you might have a dog in this fight. Buckle up, because the stakes are...

Summit Midstream's Q3 Financial Results Signal Growth

Summit Midstream Delivers Strong Q3 Results Good grief, you'd think the grease is sliding off the griddle with these numbers. Summit Midstream Corporation (NYSE:SMC) is putting up figures that ought to make even the most poker-faced of traders crack a smile. We've got a net income sitting pretty at $15.9 million, and an Adjusted EBITDA that's climbed up to $70.7 million....

New Metrics Aim to Elevate Organ Procurement Performance

Revamping Organ Procurement: A New Approach In the tangled web of healthcare, the organ donation system stands as a lifeline that's often tangled in its metrics. The latest stride by the Association of Organ Procurement Organizations (AOPO) might put some untethered efforts in line. With an announcement on November 9, 2026, the AOPO unveiled three fresh performance...

Bimbo Bakeries Teamsters Gear Up for Strike in NJ

A Brewing Storm at Bimbo Bakeries The morning air in East Brunswick fills with more than just the scent of fresh bread; there’s a tension you can slice through with a butter knife. Unwavering and fired-up, over 90 workers at Bimbo Bakeries have thrown their hats into the ring, ready to strike to protect something as sacred as the dough they churn—Teamsters' health...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Specialty1 Partners: Top Workplaces Triumph in 2026

Employees Crown Specialty1 Partners a Workplace Gem There are only a few things in the business world sweeter than being named a Top Workplace, and flying that banner proudly is exactly what Specialty1 Partners gets to do. Named a winner by the Houston Chronicle in 2026, this recognition is no regular accolade. It's built on the raw honesty that employee surveys provide,...